NGVT · Ingevity Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA margin from continuing operations non-GAAP | 36.6% | Second Quarter 2026 | — |
|
|
|||
| Free cash flow non-GAAP | $89.1M | Second Quarter 2026 | — |
|
|
|||
| Adjusted EBITDA from continuing operations non-GAAP | $91.5M | first quarter 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 30.8% | Full Year 2025 | — |
| Net leverage non-GAAP | 2.6 | Full Year 2025 | — |
| Total adjusted EBITDA, from continuing and discontinued operations non-GAAP | $397.5M | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NGVT
this stock
Ingevity Corp
|
$2.64B | +29.7% | -2.7% | 50.8 | 3.6% |
|
LIN
Linde PLC
|
$222.53B | +13.2% | +3.0% | 31.1 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.61B | +4.0% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$87.44B | +10.8% | +2.1% | 33.2 | 2.6% |
|
ECL
Ecolab Inc.
|
$77.40B | +5.2% | +2.2% | 37.1 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NGVT | -1.4% | +0.3% | +8.6% | +5.0% | +29.7% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -1.8% | -4.1% | -5.2% | +1.1% | +15.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.